应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
WHWK Whitehawk Therapeutics, Inc.
交易中 07-15 13:11:26 EDT
2.00
-0.05
-2.68%
最高
2.05
最低
1.99
成交量
6.18万
今开
2.02
昨收
2.05
日振幅
2.93%
总市值
9,398万
流通市值
4,359万
总股本
4,711万
成交额
12.45万
换手率
0.28%
流通股本
2,185万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Whitehawk Therapeutics, Inc.2025财年第一财季实现净利润73.02百万美元,同比增加499.23%
市场透视 · 05-17
Whitehawk Therapeutics, Inc.2025财年第一财季实现净利润73.02百万美元,同比增加499.23%
Whitehawk Therapeutics(WHWK.US):2025年Q1财报实现营收714.5万美元,前值为535.3万美元;每股收益为1.83美元,前值为-0.68美元。
金融界 · 05-08
Whitehawk Therapeutics(WHWK.US):2025年Q1财报实现营收714.5万美元,前值为535.3万美元;每股收益为1.83美元,前值为-0.68美元。
加载更多
公司概况
公司名称:
Whitehawk Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Whitehawk Therapeutics, Inc.于2007年11月16日在特拉华州成立。该公司是一家临床阶段的生物制药公司,为基因定义的癌症开发精准疗法。该公司的主要目标是为mTOR通路驱动因子变化的癌症患者带来转化疗法,例如TSC1或TSC2基因的变化,而mTOR抑制剂由于药理学、有效药物递送、安全性或有效性问题而没有或不能得到有效利用。Aadi的主要产品是FYARROTM,这是一种mTOR抑制剂,可与人类蛋白质结合,并显示出更高的肿瘤积累、更大的mTOR靶点抑制和增强的肿瘤生长抑制。
发行价格:
--
{"stockData":{"symbol":"WHWK","market":"US","secType":"STK","nameCN":"Whitehawk Therapeutics, Inc.","latestPrice":1.995,"timestamp":1752599020233,"preClose":2.05,"halted":0,"volume":61840,"delay":0,"floatShares":21851160,"shares":47109293,"eps":0.914523,"marketStatus":"交易中","change":-0.055,"latestTime":"07-15 13:11:26 EDT","open":2.02,"high":2.05,"low":1.99,"amount":124516.651912,"amplitude":0.029268,"askPrice":2,"askSize":700,"bidPrice":1.99,"bidSize":708,"shortable":3,"etf":0,"ttmEps":0.914523,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752609600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":2.05,"preHourTrading":{"tag":"盘前","latestPrice":1.99,"preClose":2.05,"latestTime":"09:17 EDT","volume":11,"amount":21.89,"timestamp":1752585475786},"postHourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.05,"latestTime":"19:31 EDT","volume":13,"amount":26.65,"timestamp":1752535868458},"volumeRatio":0.754803,"impliedVol":1.1611,"impliedVolPercentile":0.1358},"requestUrl":"/m/hq/s/WHWK","defaultTab":"news","newsList":[{"id":"2536840885","title":"Whitehawk Therapeutics, Inc.2025财年第一财季实现净利润73.02百万美元,同比增加499.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536840885","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536840885?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497657,"startTime":"0","endTime":"0","summary":"5月18日,Whitehawk Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为73.02百万美元,同比增加499.23%;其中营业收入为7.15百万美元,同比增加33.64%,每股基本收益为1.84美元。机构评级:截至2025年5月18日,当前有1家机构对Whitehawk Therapeutics, Inc.目标价做出预测,其中目标均价为2.00美元,其中最低目标价为2.00美元,最高目标价为2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000548a6e2d96b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000548a6e2d96b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WHWK","LENZ"],"gpt_icon":1},{"id":"2534916217","title":"Whitehawk Therapeutics(WHWK.US):2025年Q1财报实现营收714.5万美元,前值为535.3万美元;每股收益为1.83美元,前值为-0.68美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534916217","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534916217?lang=zh_cn&edition=full","pubTime":"2025-05-09 04:56","pubTimestamp":1746737808,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics(WHWK.US):2025年Q1财报实现营收714.5万美元,前值为535.3万美元;每股收益为1.83美元,前值为-0.68美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09045650243077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["WHWK","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.whitehawktx.com","stockEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.2202},{"period":"6month","weight":-0.3673},{"period":"1year","weight":0.3226},{"period":"ytd","weight":-0.3502}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1622},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1158},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Whitehawk Therapeutics, Inc.于2007年11月16日在特拉华州成立。该公司是一家临床阶段的生物制药公司,为基因定义的癌症开发精准疗法。该公司的主要目标是为mTOR通路驱动因子变化的癌症患者带来转化疗法,例如TSC1或TSC2基因的变化,而mTOR抑制剂由于药理学、有效药物递送、安全性或有效性问题而没有或不能得到有效利用。Aadi的主要产品是FYARROTM,这是一种mTOR抑制剂,可与人类蛋白质结合,并显示出更高的肿瘤积累、更大的mTOR靶点抑制和增强的肿瘤生长抑制。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.179486},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.0383},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.227585},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.018337},{"month":5,"riseRate":0.857143,"avgChangeRate":0.190811},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.069397},{"month":7,"riseRate":0.5,"avgChangeRate":-0.005365},{"month":8,"riseRate":0.571429,"avgChangeRate":0.031928},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.003937},{"month":10,"riseRate":0,"avgChangeRate":-0.14358},{"month":11,"riseRate":0.714286,"avgChangeRate":0.092547},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.101414}],"exchange":"NASDAQ","name":"Whitehawk Therapeutics, Inc.","nameEN":"Whitehawk Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Whitehawk Therapeutics, Inc.(WHWK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Whitehawk Therapeutics, Inc.(WHWK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Whitehawk Therapeutics, Inc.,WHWK,Whitehawk Therapeutics, Inc.股票,Whitehawk Therapeutics, Inc.股票老虎,Whitehawk Therapeutics, Inc.股票老虎国际,Whitehawk Therapeutics, Inc.行情,Whitehawk Therapeutics, Inc.股票行情,Whitehawk Therapeutics, Inc.股价,Whitehawk Therapeutics, Inc.股市,Whitehawk Therapeutics, Inc.股票价格,Whitehawk Therapeutics, Inc.股票交易,Whitehawk Therapeutics, Inc.股票购买,Whitehawk Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Whitehawk Therapeutics, Inc.(WHWK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Whitehawk Therapeutics, Inc.(WHWK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}